COPS5 and hepatocellular carcinoma: Moreover, recent studies showed that in the orthotopic transplant mouse models of human HCC, the systemic RNA interference targeting Jab1/CSN5 has strong potency without significant toxicity and suggested its clinical application in treating HCC disease [21, 22].